Skip to main content

Medicus Pharma Ltd.

MDCX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001997296

No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.

Other share classesMDCXW

Q1 2026 vs. Q4 2025

How the institutions holding Medicus Pharma Ltd. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of MDCX: Q4 2025 compared with Q1 2026
MeasureQ4 2025Q1 2026Change
Holders21210
Shares3.94M2.32M−1.62M (−41.1%)
Value$6.03M$301.6K−$5.73M (−95.0%)

New holders (7)

Institutions that held Medicus Pharma Ltd. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to MDCX in Q1 2026
InstitutionSharesValue% of portfolio
Virtu Financial LLC74,045$34.0K0.00%
Citadel Advisors LLC17,824$8.18K0.00%
Two Sigma Securities, LLC15,617$7.17K0.00%
LPL Financial LLC15,612$7.17K0.00%
Marathon Capital Management15,500$7.12K0.00%
StoneX Group Inc.15,169$6.96K0.00%
Tower Research Capital LLC (TRC)121$560.00%

Sold out (7)

Institutions that held Medicus Pharma Ltd. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of MDCX in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Armistice Capital, LLC1,810,960$2.77M
Jane Street Group, LLC60,337$92.3K
Susquehanna International Group, LLP40,162$61.4K
HRT Financial LP27,529$42.0K
Two Sigma Investments, LP12,319$18.8K
Larson Financial Group LLC1,000$1.53K
DAGCO, Inc.349$534